TargetMol Chemicals Inc.회사는 제품 목록을 제공합니다.

회사 명:TargetMol Chemicals Inc.

전화:-

이메일:marketing@targetmol.com

국적:China

총 제품 수:19696

106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197

제품 카탈로그

EG01377 2HCl		2749438-61-5
Etamicastat		760173-05-5	C14H15F2N3OS
GSK1521498 free base (hydrochloride)		1007578-24-6	C24H21ClF2N4
DS88790512		2231089-95-3	C22H29N3O2
GSK2973980A		2219321-25-0	C25H19F5N4O4
Kv3 modulator 2		2101321-76-8	C21H21N3O4
FXIa-IN-1		1803271-50-2	C20H19F3N4O5
IQB-782	아미디노시스테인	40454-21-5	C4H9N3O2S
EML741		2328074-38-8	C31H49N5O2
Lp-PLA2-IN-2		2071636-15-0	C19H23FN2O4S
MBM-17S		2083621-91-2	C32H34N6O6
IRAK4-IN-6		2454244-02-9	C25H32N10O2
FAAH-IN-1		1242441-47-9	C20H19ClN4OS
FadD32 Inhibitor-1		2081969-24-4	C24H20ClN3O
(R)-MIK665		1799831-02-9	C47H44ClFN6O6S
Kv3 modulator 3		1498186-01-8	C19H18N4O3
OMDM-6		616884-67-4	C28H42N2O3
(Rac)-AMG8379		1641574-26-6	C25H16ClF2N3O5S
Ribocil-C Racemate		2309762-18-1	C21H21N7OS
MK-7145		1255204-84-2	C26H30N2O6
MARK-IN-1		1109283-93-3	C22H23F2N7OS
Ebopiprant		2005486-31-5	C30H34FN3O5S2
Glucokinase activator 1		1328987-85-4	C27H20F2N2O7S2
RAF mutant-IN-1		2340020-82-6	C23H17Cl2FN6O2S
KDM4-IN-2		2369607-62-3	C25H26N6O
PD-1-IN-22		2349372-98-9	C25H25N5O4
S-8510 phosphate		151466-23-8	C12H13N4O6P
Prolyl Hydroxylase inhibitor 1		2205125-60-4	C19H18ClN5O4
DB1976		1557397-51-9	C20H16N8Se
hDDAH-1-IN-2		2408834-77-3	C8H20N4O2
Kgp-IN-1		2097865-36-4	C19H24F4N4O3
ML218 hydrochloride		2319922-08-0	C19H27Cl3N2O
ROR agonist-1		2361528-74-5	C21H20F6N2O5S
IV-23		2326007-49-0	C18H18BrNO4
RIP2 Kinase Inhibitor 3		1398053-50-3	C19H24N4O3S
PERK-IN-3		1337532-08-7	C22H16F2N4O2
HS80		2138838-57-8	C19H22N4S
LpxH-IN-AZ1		901260-40-0	C21H22F3N3O3S
Dacarbazine hydrochloride		17925-90-5	C6H11ClN6O
Blonanserin HCl		132812-45-4	C23H31ClFN3
OT antagonist 3		925703-75-9	C21H20N6O2
Kv3 modulator 1		1380696-64-9	C20H20N4O4
MARK-IN-2		1314893-26-9	C18H18ClF2N5OS
DHODH-IN-1		1800296-63-2	C21H20F3N3O2
hDDAH-1-IN-1		1229238-69-0	C8H20N4O
QPX7728 methoxy acetoxy methy ester		2170834-57-6	C14H14BFO7
ELN318463		851600-86-7	C19H20BrClN2O3S
ERK2 IN-1		1093061-47-2	C36H34FN7O2S
IDO/TDO-IN-1		2033173-01-0	C25H24FN5
GLPG1205		1445847-37-9	C22H22N2O4
DIQ3		2258636-02-9	C23H15N5
FGFR4-IN-4		2230973-67-6	C28H32Cl2N6O5
KRAS inhibitor-4		2374152-69-7	C30H39ClN8O
Menin-MLL inhibitor 4		2169916-13-4	C32H38FN7O3
Epelsiban		872599-83-2	C30H38N4O4
LY88074 Trimethyl ether		63675-87-6	C24H20O4S
RP-001 hydrochloride		1781880-34-9	C24H25ClN4O4
Dacarbazine citrate		64038-56-8	C12H18N6O8
MCB-3681		790704-42-6	C31H32F2N4O8
HS79		2138838-56-7	C19H22N4S
hDHODH-IN-7		1644156-41-1	C21H23FN4O
EGFR-IN-1		1625677-63-5	C28H30N6O4
HL271		1422365-52-3	C13H17ClF3N5O
IDO1 and HDAC1 Inhibitor		2227044-16-6	C25H22BrFN8O4
RAS GTPase inhibitor 1		2252242-32-1	C27H28ClF4N5O2
SHMT-IN-1		1508286-18-7	C18H16Cl2N4O
NPD-1335		2376326-31-5	C28H29N3O3
GSK 690 Hydrochloride		2436760-79-9	C24H23N3O.ClH
Norverapamil-d7		263175-44-6	C26H29D7N2O4
6751-0002		51505-10-3	C17H12ClNO3
RIPK1-IN-3		2242677-36-5	C22H19F3N6O3
Pparδ agonist 1		1902161-12-9	C26H27NO5
OT antagonist 1		479080-38-1	C22H22N4O3
P-gp modulator 1		2249749-39-9	C41H72N2O6
Lp-PLA2-IN-3		2196245-16-4	C20H13ClF3N3O3S
Seltorexant hydrochloride		1293284-49-7	C21H23ClFN7O
DHODH-IN-12		1263303-93-0	C10H9N3O2
DHODH-IN-4		1148125-93-2	C17H12Cl2N2O2
DYRKs-IN-2		1386980-04-6	C32H38ClN9O3
FM26		2407981-35-3	C22H15ClF3N3O3
MAGL-IN-1		2324160-91-8	C22H24FNO3
MTH1-IN-2		901044-91-5	C24H27N3O5S
PF-06726304 acetate		2080306-28-9	C24H25Cl2N3O5
QPX7728-OH disodium		2170848-99-2	C10H6BFNaO5-
GNE684		2438637-64-8	C23 H24 N6 O3
S1PR1 modulator 1		2328109-05-1	C23H24N2O3S
Mcl1-IN-4		1580484-04-3	C28H26N2O5S
DC41		1354787-69-1	C37H34ClN5O4S
OTS186935 trihydrochloride		2093401-85-3	C25H27Cl2N5O2
RORγt Inverse agonist 3		2364429-77-4	C29H31Cl2N5O4S
NSC 601980		2070018-27-6	C15H12N4
HAT-IN-1		1889281-94-0	C23H18BrF4N3O4
GPR35 agonist 1		2079880-92-3	C10H4BrN5O5
PHT-7.3		1614225-93-2	C24H23N3O3S
GNE-616		2349371-81-7	C24H23F4N5O3S
EGFR-IN-1 hydrochloride		2227455-78-7	C28H31ClN6O4
NUCC-390		1060524-97-1	C23H33N5O
PI3K-IN-9		2360875-63-2	C19H23N7O
Sitravatinib malate		2244864-88-6	C37H35F2N5O9S
(Rac)-BL-918		2435589-07-2	C23H15F8N3OS